CA2606140A1 - Preparation cutanee externe - Google Patents
Preparation cutanee externe Download PDFInfo
- Publication number
- CA2606140A1 CA2606140A1 CA002606140A CA2606140A CA2606140A1 CA 2606140 A1 CA2606140 A1 CA 2606140A1 CA 002606140 A CA002606140 A CA 002606140A CA 2606140 A CA2606140 A CA 2606140A CA 2606140 A1 CA2606140 A1 CA 2606140A1
- Authority
- CA
- Canada
- Prior art keywords
- iron
- sodium
- citrate
- ferrous
- ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract 13
- 150000001875 compounds Chemical class 0.000 claims abstract 21
- 150000002506 iron compounds Chemical class 0.000 claims abstract 21
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical class NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims abstract 16
- 229960002749 aminolevulinic acid Drugs 0.000 claims abstract 15
- 150000003839 salts Chemical class 0.000 claims abstract 15
- 206010013786 Dry skin Diseases 0.000 claims abstract 10
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract 5
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract 5
- 230000037336 dry skin Effects 0.000 claims abstract 5
- 230000037303 wrinkles Effects 0.000 claims abstract 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 26
- 229910052742 iron Inorganic materials 0.000 claims 13
- UMEAURNTRYCPNR-UHFFFAOYSA-N azane;iron(2+) Chemical compound N.[Fe+2] UMEAURNTRYCPNR-UHFFFAOYSA-N 0.000 claims 12
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 229940079593 drug Drugs 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- YNVZDODIHZTHOZ-UHFFFAOYSA-K 2-hydroxypropanoate;iron(3+) Chemical compound [Fe+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YNVZDODIHZTHOZ-UHFFFAOYSA-K 0.000 claims 6
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims 6
- VAGGJWZQGWBRPQ-QTNFYWBSSA-K [Na+].[Fe+2].C(=O)([O-])C(C(=O)[O-])N[C@@H](CCC(=O)O)C(=O)[O-] Chemical compound [Na+].[Fe+2].C(=O)([O-])C(C(=O)[O-])N[C@@H](CCC(=O)O)C(=O)[O-] VAGGJWZQGWBRPQ-QTNFYWBSSA-K 0.000 claims 6
- OOIOHEBTXPTBBE-UHFFFAOYSA-N [Na].[Fe] Chemical compound [Na].[Fe] OOIOHEBTXPTBBE-UHFFFAOYSA-N 0.000 claims 6
- GLMQHZPGHAPYIO-UHFFFAOYSA-L azanium;2-hydroxypropane-1,2,3-tricarboxylate;iron(2+) Chemical compound [NH4+].[Fe+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O GLMQHZPGHAPYIO-UHFFFAOYSA-L 0.000 claims 6
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 claims 6
- FJZZHNSAKKNYJJ-QTNFYWBSSA-N diazanium;(2s)-2-(dicarboxymethylamino)pentanedioate Chemical compound [NH4+].[NH4+].OC(=O)C(C(O)=O)N[C@H](C([O-])=O)CCC([O-])=O FJZZHNSAKKNYJJ-QTNFYWBSSA-N 0.000 claims 6
- 239000011706 ferric diphosphate Substances 0.000 claims 6
- 235000007144 ferric diphosphate Nutrition 0.000 claims 6
- VEPSWGHMGZQCIN-UHFFFAOYSA-H ferric oxalate Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O VEPSWGHMGZQCIN-UHFFFAOYSA-H 0.000 claims 6
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims 6
- 229940036404 ferric pyrophosphate Drugs 0.000 claims 6
- 239000011640 ferrous citrate Substances 0.000 claims 6
- 235000019850 ferrous citrate Nutrition 0.000 claims 6
- 239000004222 ferrous gluconate Substances 0.000 claims 6
- 235000013924 ferrous gluconate Nutrition 0.000 claims 6
- 229960001645 ferrous gluconate Drugs 0.000 claims 6
- 229960001604 ferrous succinate Drugs 0.000 claims 6
- 150000003278 haem Chemical class 0.000 claims 6
- 229960003284 iron Drugs 0.000 claims 6
- 239000004313 iron ammonium citrate Substances 0.000 claims 6
- 235000000011 iron ammonium citrate Nutrition 0.000 claims 6
- ATEAWHILRRXHPW-UHFFFAOYSA-J iron(2+);phosphonato phosphate Chemical compound [Fe+2].[Fe+2].[O-]P([O-])(=O)OP([O-])([O-])=O ATEAWHILRRXHPW-UHFFFAOYSA-J 0.000 claims 6
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 claims 6
- APVZWAOKZPNDNR-UHFFFAOYSA-L iron(ii) citrate Chemical compound [Fe+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O APVZWAOKZPNDNR-UHFFFAOYSA-L 0.000 claims 6
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims 6
- MVZXTUSAYBWAAM-UHFFFAOYSA-N iron;sulfuric acid Chemical compound [Fe].OS(O)(=O)=O MVZXTUSAYBWAAM-UHFFFAOYSA-N 0.000 claims 6
- 230000003449 preventive effect Effects 0.000 claims 6
- UWSAIOMORQUEHN-UHFFFAOYSA-L sodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron(5+) Chemical compound [Na+].[Fe+5].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O UWSAIOMORQUEHN-UHFFFAOYSA-L 0.000 claims 6
- KXFFQVUPQCREHA-UHFFFAOYSA-K sodium;2-hydroxypropane-1,2,3-tricarboxylate;iron(2+) Chemical compound [Na+].[Fe+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KXFFQVUPQCREHA-UHFFFAOYSA-K 0.000 claims 6
- AEDLILNWEXDEHC-UHFFFAOYSA-M sodium;butanedioic acid;3-carboxy-3,5-dihydroxy-5-oxopentanoate Chemical compound [Na+].OC(=O)CCC(O)=O.OC(=O)CC(O)(C(O)=O)CC([O-])=O AEDLILNWEXDEHC-UHFFFAOYSA-M 0.000 claims 6
- BKJXSPNFVILSSW-UHFFFAOYSA-N n'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;iron Chemical compound [Fe].NCCNCCNCCN BKJXSPNFVILSSW-UHFFFAOYSA-N 0.000 claims 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 239000004202 carbamide Substances 0.000 claims 2
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 claims 1
- 206010040954 Skin wrinkling Diseases 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000007665 sagging Methods 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000007306 turnover Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une préparation cutanée externe comprenant un acide 5-aminolévulinique ou similaire en tant que principe actif présentant un excellent effet pour l~embellissement de la peau, tel qu~un effet de prévention et d~amélioration de la rugosité cutanée, de la peau sèche, des rides, du ramollissement de la peau et des tâches et un effet de régénération de la couche cornéenne, ainsi qu~un excellent effet d~amélioration d~une affection dermatologique telle qu~une dermatite topique. La présente invention concerne l~utilisation de la préparation cutanée externe, caractérisée par l~inclusion d~un composé de fer et d'un ou de plusieurs composés sélectionnés parmi un acide 5-aminolévulinique, un sel de celui-ci et un dérivé de celui en tant que principes actifs.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005-131171 | 2005-04-28 | ||
| JP2005131171 | 2005-04-28 | ||
| PCT/JP2005/017681 WO2006117885A1 (fr) | 2005-04-28 | 2005-09-27 | Preparation cutanee externe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2606140A1 true CA2606140A1 (fr) | 2006-11-09 |
| CA2606140C CA2606140C (fr) | 2011-07-19 |
Family
ID=37307691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2606140A Active CA2606140C (fr) | 2005-04-28 | 2005-09-27 | Preparation cutanee externe |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20090130227A1 (fr) |
| EP (1) | EP1878421B1 (fr) |
| JP (1) | JP3991063B2 (fr) |
| KR (1) | KR100929264B1 (fr) |
| CN (1) | CN101166510B (fr) |
| AU (1) | AU2005331416B2 (fr) |
| BR (1) | BRPI0520076B1 (fr) |
| CA (1) | CA2606140C (fr) |
| IL (1) | IL186871A (fr) |
| MX (1) | MX2007013623A (fr) |
| NO (1) | NO341897B1 (fr) |
| NZ (2) | NZ587597A (fr) |
| PL (1) | PL1878421T3 (fr) |
| RU (1) | RU2381022C2 (fr) |
| WO (1) | WO2006117885A1 (fr) |
| ZA (1) | ZA200708438B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080059157A (ko) | 2005-08-12 | 2008-06-26 | 릭 비. 예거 | 인간의 피부의 시각적 매력을 강화하기 위하여 반사율변형제를 가하는 시스템 및 방법 |
| US8184901B2 (en) | 2007-02-12 | 2012-05-22 | Tcms Transparent Beauty Llc | System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image |
| EP1938801A1 (fr) * | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoémulsion |
| WO2008100880A1 (fr) | 2007-02-12 | 2008-08-21 | Yeager Rick B | Système et procédé permettant d'appliquer électrostatiquement un agent sur une peau humaine |
| JP5098051B2 (ja) * | 2007-04-05 | 2012-12-12 | Ｓｂｉファーマ株式会社 | ミトコンドリア障害脳疾患治療剤及び診断剤 |
| US10092082B2 (en) | 2007-05-29 | 2018-10-09 | Tcms Transparent Beauty Llc | Apparatus and method for the precision application of cosmetics |
| DK2272538T3 (da) | 2008-04-22 | 2020-10-26 | Sbi Pharmaceuticals Co Ltd | Fremgangsmåde til påvisning af blærecancer |
| EP2305237B1 (fr) * | 2008-05-14 | 2014-04-30 | SBI Pharmaceuticals Co., Ltd. | Agent thérapeutique pour la stérilité masculine |
| KR20100122952A (ko) * | 2008-05-30 | 2010-11-23 | 제이에프이 스틸 가부시키가이샤 | 선철 제조 방법 |
| JP5295652B2 (ja) * | 2008-06-16 | 2013-09-18 | Ｓｂｉファーマ株式会社 | 光障害の軽減剤 |
| JP5081121B2 (ja) * | 2008-10-17 | 2012-11-21 | 株式会社ミルボン | 育毛剤組成物 |
| CA2935654C (fr) | 2008-10-27 | 2019-01-08 | Sbi Pharmaceuticals Co., Ltd. | Agent prophylactique/d'amelioration pour des maladies chez l'adulte comprenant l'acide 5-aminolevulinique, son ester ou un sel de celui-ci comme ingredient actif |
| CN106109455A (zh) | 2010-05-19 | 2016-11-16 | 思佰益药业股份有限公司 | 以5‑氨基乙酰丙酸或其衍生物作为有效成分的抗疟药 |
| HUE043511T2 (hu) * | 2012-07-13 | 2019-08-28 | Sbi Pharmaceuticals Co Ltd | Immuntoleranciát kiváltó szer |
| CN103054736B (zh) * | 2013-01-05 | 2015-07-15 | 陕西佰美基因股份有限公司 | 一种含有血红素的抗衰老化妆品 |
| RU2538084C1 (ru) * | 2013-07-25 | 2015-01-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздрава России) | Средство для лечения и профилактики атопического дерматита |
| KR101654028B1 (ko) * | 2015-02-17 | 2016-09-05 | 제너럴바이오(주) | 피부 도포용 화장료 조성물 및 이의 제조방법 |
| JP6773648B2 (ja) | 2015-05-11 | 2020-10-21 | 株式会社林原 | 皮膚外用剤 |
| EP3576846B1 (fr) * | 2017-02-06 | 2020-12-09 | 3Skin AS | Composition d'écran solaire |
| CA3102288A1 (fr) * | 2018-07-03 | 2020-01-09 | The Procter & Gamble Company | Methode de traitement d'une affection cutanee |
| BR102019005545A2 (pt) * | 2019-03-21 | 2020-10-06 | Natbio Ltda Me | Formulações cosméticas constituídas por uma mistura nutritiva proveniente de um processo fermentativo |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN114081851A (zh) * | 2021-11-01 | 2022-02-25 | 苏州纳美特生物科技有限公司 | 保湿喷雾 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4259318A (en) * | 1978-03-02 | 1981-03-31 | University Of Houston, Central Campus | Poison ivy relief composition |
| JPS58152805A (ja) * | 1982-03-06 | 1983-09-10 | Masayuki Shirai | 温泉水含有皮膚化粧料 |
| JP2694756B2 (ja) | 1988-08-19 | 1997-12-24 | 有限会社アイ・ビー・イー | 二価三価鉄塩配合化粧品 |
| JPH02108612A (ja) * | 1988-10-19 | 1990-04-20 | Shizen:Kk | 二価三価複合鉄塩配合化粧品 |
| JP2767318B2 (ja) | 1990-04-11 | 1998-06-18 | 株式会社コスモ総合研究所 | ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤 |
| DE4320871C2 (de) | 1993-06-24 | 1995-05-04 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure |
| JP2747644B2 (ja) | 1993-08-19 | 1998-05-06 | 株式会社コスモ総合研究所 | 植物成長調節剤 |
| WO1995016659A1 (fr) * | 1993-12-15 | 1995-06-22 | Avon Products, Inc. | Nouveaux composes conjugues de retinoides et procedes de traitement du vieillissement de la peau |
| JPH0881322A (ja) | 1994-09-16 | 1996-03-26 | Mitsui Toatsu Chem Inc | 微生物雑草防除組成物 |
| GB9510162D0 (en) * | 1995-05-19 | 1995-07-12 | Bouras Elias | Compositions for the treatment of skin conditions |
| US6372234B1 (en) * | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
| JP3644809B2 (ja) | 1997-10-15 | 2005-05-11 | コスモ石油株式会社 | 頭部用外用剤 |
| JP3948588B2 (ja) | 1998-03-05 | 2007-07-25 | 株式会社資生堂 | 皮膚バリアー機能回復促進剤 |
| JP2000281556A (ja) | 1999-03-29 | 2000-10-10 | Shiseido Co Ltd | 皮膚外用剤 |
| JP3970492B2 (ja) * | 1999-12-14 | 2007-09-05 | コスモ石油株式会社 | ピーリング用組成物 |
| NO20002428D0 (no) * | 2000-05-10 | 2000-05-10 | Radiumhospitalets Forskningsst | Hudpreparat |
| JP2002020294A (ja) | 2000-06-30 | 2002-01-23 | Lion Corp | 皮膚外用剤 |
| FR2811563B1 (fr) * | 2000-07-13 | 2003-06-20 | Oreal | Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes |
| JP2002179518A (ja) * | 2000-12-14 | 2002-06-26 | Kyowa Hakko Kogyo Co Ltd | 化粧料 |
| US6565864B2 (en) * | 2000-12-28 | 2003-05-20 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Skin care product containing retinoids and phytoestrogens in a dual compartment package |
| ITMI20010685A1 (it) * | 2001-03-30 | 2002-09-30 | Biochimici Psn S P A | Acido delta-amminolevulinico per uso medico e cosmetico |
| JP4754731B2 (ja) | 2001-07-31 | 2011-08-24 | コスモ石油株式会社 | 豚成育促進剤及び豚成育促進方法 |
| EP1312353A1 (fr) * | 2001-11-16 | 2003-05-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Méthode d'épilation |
| AT410633B (de) | 2002-04-25 | 2003-06-25 | Oekopharm Forschungs Und Entwi | Verwendung eines auf einer biologisch inerten, hochdispersen matrix getrockneten stutenmilchkonzentrats |
| US20030212127A1 (en) * | 2002-05-09 | 2003-11-13 | Bradley Pharmaceuticals, Inc. | Method of treating actinic keratosis |
| DE20213787U1 (de) * | 2002-09-04 | 2002-12-19 | Warner Lambert Co | Hautpflegemittel |
| US20040048842A1 (en) * | 2002-09-10 | 2004-03-11 | Mcmillan Kathleen | Method of treating skin disorders |
| US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| JP4425554B2 (ja) | 2003-03-19 | 2010-03-03 | 日本メナード化粧品株式会社 | 皮膚外用剤 |
| US7258875B2 (en) * | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
| ES2464169T3 (es) * | 2004-04-28 | 2014-05-30 | Cosmo Oil Co., Ltd. | Restaurador capilar |
-
2005
- 2005-09-27 CA CA2606140A patent/CA2606140C/fr active Active
- 2005-09-27 WO PCT/JP2005/017681 patent/WO2006117885A1/fr active Application Filing
- 2005-09-27 JP JP2006536992A patent/JP3991063B2/ja active Active
- 2005-09-27 AU AU2005331416A patent/AU2005331416B2/en active Active
- 2005-09-27 NZ NZ587597A patent/NZ587597A/en unknown
- 2005-09-27 EP EP05787723.5A patent/EP1878421B1/fr active Active
- 2005-09-27 US US11/912,433 patent/US20090130227A1/en not_active Abandoned
- 2005-09-27 MX MX2007013623A patent/MX2007013623A/es active IP Right Grant
- 2005-09-27 KR KR1020077027153A patent/KR100929264B1/ko active IP Right Grant
- 2005-09-27 CN CN200580049628XA patent/CN101166510B/zh active Active
- 2005-09-27 BR BRPI0520076A patent/BRPI0520076B1/pt active IP Right Grant
- 2005-09-27 PL PL05787723T patent/PL1878421T3/pl unknown
- 2005-09-27 NZ NZ562874A patent/NZ562874A/en unknown
- 2005-09-27 RU RU2007143517/15A patent/RU2381022C2/ru active
-
2007
- 2007-10-03 ZA ZA200708438A patent/ZA200708438B/xx unknown
- 2007-10-23 IL IL186871A patent/IL186871A/en active IP Right Grant
- 2007-11-22 NO NO20076019A patent/NO341897B1/no unknown
-
2010
- 2010-11-12 US US12/945,177 patent/US9333156B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NO20076019L (no) | 2008-01-28 |
| MX2007013623A (es) | 2008-02-12 |
| WO2006117885A8 (fr) | 2006-12-21 |
| NO341897B1 (no) | 2018-02-12 |
| CA2606140C (fr) | 2011-07-19 |
| ZA200708438B (en) | 2008-09-25 |
| IL186871A0 (en) | 2008-06-05 |
| RU2007143517A (ru) | 2009-06-10 |
| JP3991063B2 (ja) | 2007-10-17 |
| AU2005331416B2 (en) | 2009-10-01 |
| KR100929264B1 (ko) | 2009-12-01 |
| AU2005331416A1 (en) | 2006-11-09 |
| WO2006117885A1 (fr) | 2006-11-09 |
| EP1878421B1 (fr) | 2019-04-03 |
| RU2381022C2 (ru) | 2010-02-10 |
| US9333156B2 (en) | 2016-05-10 |
| CN101166510A (zh) | 2008-04-23 |
| CN101166510B (zh) | 2012-03-07 |
| BRPI0520076B1 (pt) | 2018-05-08 |
| PL1878421T3 (pl) | 2019-09-30 |
| US20110060042A1 (en) | 2011-03-10 |
| NZ562874A (en) | 2010-09-30 |
| US20090130227A1 (en) | 2009-05-21 |
| KR20080003916A (ko) | 2008-01-08 |
| IL186871A (en) | 2015-08-31 |
| EP1878421A1 (fr) | 2008-01-16 |
| EP1878421A4 (fr) | 2015-11-18 |
| BRPI0520076A2 (pt) | 2009-08-18 |
| JPWO2006117885A1 (ja) | 2008-12-18 |
| NZ587597A (en) | 2011-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2606140A1 (fr) | Preparation cutanee externe | |
| US5834513A (en) | Oxa diacids and related compounds for treating skin conditions | |
| US5847003A (en) | Oxa acids and related compounds for treating skin conditions | |
| JP3076787B2 (ja) | アセロラチェリー発酵体を含有する皮膚白色化組成物 | |
| CA2564043A1 (fr) | Fortifiant pour cheveux | |
| US6197317B1 (en) | Composition and method for the treatment of skin | |
| US20120207688A1 (en) | Rosacea Topical Skin Treatment Method and Formulation | |
| JP5295652B2 (ja) | 光障害の軽減剤 | |
| JP3629283B2 (ja) | 皮膚外用剤 | |
| EP2316444A2 (fr) | Utilisation des acides alkanedicarboxiliques et des retinoides pour le traitement de rosacea et autres maladies inflammatoires de la peau | |
| KR20050113669A (ko) | 피부 외용 ｌ-카르니틴 조성물 | |
| WO2007102090A3 (fr) | Formulation topique | |
| US5843998A (en) | Skin blemish treatment | |
| DE69939722D1 (de) | Fulvinsäure und deren Verwendung in der Behandlung von Entzündungen | |
| WO2005049827B1 (fr) | Ppmp utilise comme inhibiteur du catabolisme du ceramide pour traiter le cancer | |
| CA2124748A1 (fr) | Utilisation d'o-esters de la l-carnitine et d'acides aromatiques dans la production de compositions pharmaceutiques pour le traitement des dermatoses | |
| JP2006213633A (ja) | 抗菌剤 | |
| EP0250300A1 (fr) | Utilisation des mélanges de sel de zinc et de la vitamine B6 pour enrayer les processus alopéciques et/ou séborrhéiques | |
| EP2476408A1 (fr) | Préparation externe contenant un esterphosphorique de pantéthine | |
| WO2001070235A1 (fr) | Composition a base de sphingolipide et de beta-hydroxy-acide pour les soins de la peau | |
| JP2001172154A (ja) | ピーリング用組成物 | |
| FR2894821A1 (fr) | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations | |
| US7241808B2 (en) | Composition for treatment of skin and method for stabilizing the composition | |
| FR2773074A1 (fr) | Composition a base d'alpha-hydroxy-acides et de ceramides utilisable par voie topique pour le traitement d'affections dermatologiques | |
| JP2007246459A (ja) | 肌荒れの予防、改善に好適な皮膚外用剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |